Predictive Oncology SG&A Expense (TTM) Insights

Predictive Oncology Inc (POAI)

1.04 0.00 (0.00%) USD | NASDAQ | Jun 28, 16:00

1.02 -0.02 (-1.92%) After-Hours: 07:50

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2009. Upgrade now.

Date	Value
March 31, 2024	11.44M
December 31, 2023	10.71M
September 30, 2023	12.03M
June 30, 2023	12.73M
March 31, 2023	12.22M
December 31, 2022	12.47M
September 30, 2022	12.82M
June 30, 2022	11.43M
March 31, 2022	11.05M
December 31, 2021	11.71M
September 30, 2021	10.01M
June 30, 2021	10.12M
March 31, 2021	11.23M
December 31, 2020	10.94M
September 30, 2020	11.38M
June 30, 2020	12.08M
March 31, 2020	12.73M
December 31, 2019	11.69M
September 30, 2019	11.66M
June 30, 2019	9.993M
March 31, 2019	7.282M
December 31, 2018	7.022M
September 30, 2018	4.957M
June 30, 2018	4.496M
March 31, 2018	5.841M

Date	Value
December 31, 2017	5.528M
September 30, 2017	6.800M
June 30, 2017	6.747M
March 31, 2017	6.484M
December 31, 2016	6.801M
September 30, 2016	6.907M
June 30, 2016	6.964M
March 31, 2016	5.594M
December 31, 2015	3.882M
September 30, 2015	4.205M
June 30, 2015	4.523M
March 31, 2015	5.469M
December 31, 2014	7.034M
September 30, 2014	7.015M
June 30, 2014	9.483M
March 31, 2014	8.744M
December 31, 2013	9.206M
September 30, 2013	8.619M
June 30, 2013	7.737M
March 31, 2013	8.664M
December 31, 2012	7.220M
September 30, 2012	8.208M
June 30, 2012	6.001M
March 31, 2012	4.389M
December 31, 2011	4.146M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

10.01M

Minimum

Sep 2021

12.82M

Maximum

Sep 2022

11.60M

Average

11.66M

Median

Sep 2019

SG&A Expense (TTM) Benchmarks